Symbols / RMTI Stock $0.79 -0.55% Rockwell Medical, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NCM
RMTI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Dr. Mark Strobeck Ph.D.
Exch · Country NCM · United States
Market Cap 31.26M
Enterprise Value 18.25M
Income -5.47M
Sales 69.26M
FCF (ttm) -1.52M
Book/sh 0.94
Cash/sh 0.63
Employees 157
Insider 10d —
IPO Jan 27, 1998
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 11.32
PEG 4.43
P/S 0.45
P/B 0.84
P/C —
EV/EBITDA -7.30
EV/Sales 0.26
Quick Ratio 3.46
Current Ratio 3.98
Debt/Eq 33.73
LT Debt/Eq —
EPS (ttm) -0.15
EPS next Y 0.07
EPS Growth —
Revenue Growth -25.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-05-07
ROA -5.04%
ROE -15.28%
ROIC —
Gross Margin 16.89%
Oper. Margin -2.17%
Profit Margin -7.67%
Shs Outstand 39.47M
Shs Float 35.20M
Insider Own 12.27%
Instit Own 9.41%
Short Float 2.80%
Short Ratio 3.75
Short Interest 990.64K
52W High 2.10
vs 52W High -62.28%
52W Low 0.74
vs 52W Low 7.04%
Beta 1.66
Impl. Vol. 3.88%
Rel Volume 1.44
Avg Volume 262.60K
Volume 379.09K
Target (mean) $3.00
Tgt Median $3.00
Tgt Low $2.00
Tgt High $4.00
# Analysts 2
Recom Strong_buy
Prev Close $0.80
Price $0.79
Change -0.55%
About

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$3.00
Mean price target
2. Current target
$0.79
Latest analyst target
3. DCF / Fair value
$-0.69
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.79
Low
$2.00
High
$4.00
Mean
$3.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-30 main HC Wainwright & Co. Buy → Buy $2
2026-01-26 reit HC Wainwright & Co. Buy → Buy $3
2025-11-13 main HC Wainwright & Co. Buy → Buy $3
2025-03-24 main HC Wainwright & Co. Buy → Buy $3
2024-12-23 reit HC Wainwright & Co. Buy → Buy $7
2024-11-25 main HC Wainwright & Co. Buy → Buy $7
2024-11-14 init Rodman & Renshaw — → Buy $5
2024-08-12 reit HC Wainwright & Co. Buy → Buy $9
2024-05-16 reit HC Wainwright & Co. Buy → Buy $9
2024-03-25 main HC Wainwright & Co. Buy → Buy $9
2023-11-15 reit HC Wainwright & Co. Buy → Buy $11
2023-10-05 init Maxim Group — → Buy $5
2023-10-04 reit HC Wainwright & Co. Buy → Buy $11
2023-09-28 reit HC Wainwright & Co. Buy → Buy $11
2023-08-15 reit HC Wainwright & Co. Buy → Buy $11
2023-07-17 main HC Wainwright & Co. Buy → Buy $11
2023-05-30 main HC Wainwright & Co. Buy → Buy $9
2023-05-02 reit HC Wainwright & Co. — → Buy $7
2023-04-04 reit HC Wainwright & Co. — → Buy $7
2023-02-13 reit HC Wainwright & Co. — → Buy $7
News
RSS: Latest RMTI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-02 NERI JESSE Chief Financial Officer — 886 $0.84 $740
2026-01-02 HUNTER HEATHER R. Chief Operating Officer — 2,868 $0.84 $2,396
2025-11-18 COOPER JOHN G Director — 5,079 $0.87 $4,419
2025-11-17 DAWSON JOSEPH H. Director — 25,000 $0.00 $0
2025-10-01 STROBECK MARK Chief Executive Officer — 6,926 $1.19 $8,242
2025-10-01 NERI JESSE Chief Financial Officer — 886 $1.19 $1,054
2025-10-01 CHOLE TIMOTHY Officer — 2,868 $1.19 $3,413
2025-10-01 HUNTER HEATHER R. Chief Operating Officer — 2,868 $1.19 $3,413
2025-07-01 STROBECK MARK Chief Executive Officer — 6,926 $0.82 $5,679
2025-07-01 STROBECK MARK Chief Executive Officer — 6,926 $0.82 $5,679
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
69.26
-31.76%
101.49
+21.38%
83.61
+14.84%
72.81
Operating Revenue
69.26
-31.76%
101.49
+21.38%
83.61
+14.84%
72.81
Cost Of Revenue
57.56
-31.48%
84.00
+12.14%
74.91
+8.98%
68.73
Reconciled Cost Of Revenue
57.56
-31.48%
84.00
+12.14%
74.91
+8.98%
68.73
Gross Profit
11.70
-33.11%
17.48
+100.87%
8.70
+113.49%
4.08
Operating Expense
16.39
-2.90%
16.88
+9.77%
15.37
-26.29%
20.86
Research And Development
0.00
-100.00%
0.02
-98.28%
1.11
-64.51%
3.12
Selling General And Administration
16.39
-2.79%
16.86
+18.15%
14.27
-19.57%
17.74
Selling And Marketing Expense
2.35
-14.37%
2.75
+29.36%
2.12
+1.48%
2.09
General And Administrative Expense
14.03
-0.54%
14.11
+16.19%
12.14
-22.39%
15.64
Other Gand A
14.03
-0.54%
14.11
+16.19%
12.14
-22.39%
15.64
Total Expenses
73.95
-26.70%
100.88
+11.74%
90.28
+0.77%
89.59
Operating Income
-4.69
-871.55%
0.61
+109.12%
-6.67
+60.25%
-16.78
Total Operating Income As Reported
-4.69
-871.55%
0.61
+109.12%
-6.67
+60.25%
-16.78
EBITDA
-2.00
-167.64%
2.95
+162.93%
-4.69
+70.97%
-16.17
Normalized EBITDA
-2.27
-178.65%
2.88
+157.43%
-5.01
+68.99%
-16.17
Reconciled Depreciation
2.19
+0.55%
2.18
+50.97%
1.44
+150.69%
0.58
EBIT
-4.19
-641.34%
0.77
+112.61%
-6.14
+63.34%
-16.74
Total Unusual Items
0.27
+260.81%
0.07
-76.95%
0.32
+7925.00%
0.00
Total Unusual Items Excluding Goodwill
0.27
+260.81%
0.07
-76.95%
0.32
+7925.00%
0.00
Net Income
-5.31
-1007.08%
-0.48
+94.31%
-8.44
+54.82%
-18.68
Pretax Income
-5.31
-1007.08%
-0.48
+94.31%
-8.44
+54.82%
-18.68
Net Non Operating Interest Income Expense
-0.89
+23.41%
-1.16
+44.40%
-2.09
-9.83%
-1.90
Interest Expense Non Operating
1.12
-10.37%
1.25
-45.50%
2.30
+18.85%
1.94
Net Interest Income
-0.89
+23.41%
-1.16
+44.40%
-2.09
-9.83%
-1.90
Interest Expense
1.12
-10.37%
1.25
-45.50%
2.30
+18.85%
1.94
Interest Income Non Operating
0.23
+154.35%
0.09
-56.40%
0.21
+539.39%
0.03
Interest Income
0.23
+154.35%
0.09
-56.40%
0.21
+539.39%
0.03
Other Income Expense
0.27
+260.81%
0.07
-76.95%
0.32
+7925.00%
0.00
Gain On Sale Of Security
0.27
+260.81%
0.07
-76.95%
0.32
+7925.00%
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-5.31
-1007.08%
-0.48
+94.31%
-8.44
+54.82%
-18.68
Net Income From Continuing Operation Net Minority Interest
-5.31
-1007.08%
-0.48
+94.31%
-8.44
+54.82%
-18.68
Net Income From Continuing And Discontinued Operation
-5.31
-1007.08%
-0.48
+94.31%
-8.44
+54.82%
-18.68
Net Income Continuous Operations
-5.31
-1007.08%
-0.48
+94.31%
-8.44
+54.82%
-18.68
Normalized Income
-5.58
-907.40%
-0.55
+93.68%
-8.76
+53.11%
-18.68
Net Income Common Stockholders
-5.47
-599.10%
-0.78
+90.90%
-8.59
+54.02%
-18.68
Otherunder Preferred Stock Dividend
0.15
-49.34%
0.30
+101.33%
0.15
—
Diluted EPS
-0.15
-400.00%
-0.03
+91.89%
-0.37
+80.42%
-1.89
Basic EPS
-0.15
-400.00%
-0.03
+91.89%
-0.37
+80.42%
-1.89
Basic Average Shares
35.97
+15.83%
31.06
+33.17%
23.32
+136.38%
9.87
Diluted Average Shares
35.97
+15.83%
31.06
+33.17%
23.32
+136.38%
9.87
Diluted NI Availto Com Stockholders
-5.47
-599.10%
-0.78
+90.90%
-8.59
+54.02%
-18.68
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
57.15
-3.48%
59.21
+13.48%
52.17
+11.88%
46.63
Current Assets
38.16
+3.06%
37.03
+28.71%
28.77
-18.52%
35.31
Cash Cash Equivalents And Short Term Investments
25.00
+15.72%
21.60
+97.55%
10.94
-49.12%
21.49
Cash And Cash Equivalents
10.71
-31.61%
15.66
+74.35%
8.98
-11.08%
10.10
Other Short Term Investments
14.29
+140.51%
5.94
+204.30%
1.95
-82.86%
11.39
Receivables
8.14
-1.79%
8.29
-23.94%
10.90
+74.17%
6.26
Accounts Receivable
8.14
-1.79%
8.29
-23.94%
10.90
+74.17%
6.26
Gross Accounts Receivable
—
8.29
-24.50%
10.98
+74.54%
6.29
Allowance For Doubtful Accounts Receivable
—
0.00
+100.00%
-0.08
-145.45%
-0.03
Inventory
3.42
-40.74%
5.78
-1.58%
5.87
+0.98%
5.81
Raw Materials
1.85
-38.60%
3.01
+33.78%
2.25
-32.86%
3.35
Work In Process
0.20
-45.78%
0.37
+4.56%
0.35
+0.00%
0.35
Finished Goods
1.38
-42.65%
2.40
-26.57%
3.27
+54.83%
2.11
Prepaid Assets
—
—
—
—
Other Current Assets
1.60
+17.66%
1.36
+27.85%
1.06
-39.08%
1.75
Total Non Current Assets
18.98
-14.41%
22.18
-5.23%
23.40
+106.65%
11.32
Net PPE
7.85
-24.12%
10.34
-6.12%
11.02
+28.04%
8.61
Gross PPE
18.57
-10.49%
20.75
+4.66%
19.82
+22.05%
16.24
Accumulated Depreciation
-10.72
-3.07%
-10.40
-18.15%
-8.80
-15.30%
-7.64
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
13.06
-5.51%
13.82
+6.49%
12.98
+67.07%
7.77
Other Properties
3.95
-26.46%
5.37
-1.05%
5.42
-24.87%
7.22
Leases
1.57
+0.32%
1.56
+9.77%
1.42
+13.30%
1.26
Goodwill And Other Intangible Assets
10.58
-4.95%
11.13
-4.73%
11.68
+1168.19%
0.92
Goodwill
0.92
+0.00%
0.92
+0.00%
0.92
+0.00%
0.92
Other Intangible Assets
9.66
-5.40%
10.21
-5.13%
10.76
—
Other Non Current Assets
0.56
-21.25%
0.71
+0.14%
0.70
-60.81%
1.80
Total Liabilities Net Minority Interest
20.16
-24.26%
26.62
-13.79%
30.88
-5.06%
32.53
Current Liabilities
9.58
-32.01%
14.09
-15.30%
16.64
-5.96%
17.69
Payables And Accrued Expenses
3.69
-40.65%
6.22
-30.83%
9.00
+1.32%
8.88
Payables
2.00
-30.32%
2.87
-36.47%
4.52
+11.42%
4.05
Accounts Payable
2.00
-30.32%
2.87
-36.47%
4.52
+11.42%
4.05
Current Accrued Expenses
1.70
-49.48%
3.35
-25.15%
4.48
-7.17%
4.83
Pensionand Other Post Retirement Benefit Plans Current
2.64
-9.52%
2.92
+9.49%
2.67
-7.20%
2.87
Current Debt And Capital Lease Obligation
1.89
-22.40%
2.43
+11.45%
2.18
-47.26%
4.14
Current Debt
0.26
-1.49%
0.27
+9.84%
0.24
-88.57%
2.13
Other Current Borrowings
—
—
—
1.63
Current Capital Lease Obligation
1.62
-24.99%
2.17
+11.66%
1.94
-3.29%
2.00
Current Deferred Liabilities
1.36
-46.06%
2.51
-9.86%
2.79
+55.20%
1.80
Current Deferred Revenue
0.36
+148.95%
0.14
-50.52%
0.29
-83.92%
1.80
Total Non Current Liabilities Net Minority Interest
10.58
-15.54%
12.53
-12.03%
14.24
-4.00%
14.84
Long Term Debt And Capital Lease Obligation
10.58
-4.67%
11.10
-1.37%
11.26
-7.92%
12.22
Long Term Debt
8.83
+4.18%
8.47
+2.16%
8.29
+9.77%
7.55
Long Term Capital Lease Obligation
1.76
-33.16%
2.63
-11.24%
2.96
-36.54%
4.67
Non Current Deferred Liabilities
0.00
-100.00%
1.43
-51.97%
2.98
+14.42%
2.60
Non Current Deferred Revenue
0.00
-100.00%
0.43
-9.68%
0.47
-81.73%
2.60
Other Non Current Liabilities
—
—
0.01
+0.00%
0.01
Stockholders Equity
36.98
+13.49%
32.59
+53.05%
21.29
+50.94%
14.11
Common Stock Equity
36.98
+13.49%
32.59
+53.05%
21.29
+50.94%
14.11
Capital Stock
0.00
+33.33%
0.00
+0.00%
0.00
+200.00%
0.00
Common Stock
0.00
+33.33%
0.00
+0.00%
0.00
+200.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
39.41
+15.70%
34.06
+16.91%
29.13
+139.49%
12.16
Ordinary Shares Number
39.41
+15.70%
34.06
+16.91%
29.13
+139.49%
12.16
Additional Paid In Capital
439.84
+2.24%
430.21
+2.80%
418.49
+3.92%
402.70
Retained Earnings
-402.99
-1.34%
-397.68
-0.12%
-397.20
-2.17%
-388.76
Gains Losses Not Affecting Retained Earnings
0.13
+142.59%
0.05
+5500.00%
-0.00
-100.61%
0.16
Other Equity Adjustments
0.13
+142.59%
0.05
+5500.00%
-0.00
-100.61%
0.16
Total Equity Gross Minority Interest
36.98
+13.49%
32.59
+53.05%
21.29
+50.94%
14.11
Total Capitalization
45.81
+11.57%
41.06
+38.78%
29.58
+36.58%
21.66
Working Capital
28.58
+24.60%
22.94
+89.06%
12.13
-31.14%
17.62
Invested Capital
46.07
+11.48%
41.33
+38.55%
29.83
+25.35%
23.80
Net Debt
—
—
—
—
Capital Lease Obligations
3.38
-29.47%
4.79
-2.18%
4.90
-26.55%
6.67
Net Tangible Assets
26.40
+23.05%
21.46
+123.27%
9.61
-27.11%
13.19
Tangible Book Value
26.40
+23.05%
21.46
+123.27%
9.61
-27.11%
13.19
Current Notes Payable
0.26
-1.49%
0.27
+9.84%
0.24
-51.49%
0.50
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-0.66
-115.68%
4.20
+144.65%
-9.41
+44.40%
-16.93
Cash Flow From Continuing Operating Activities
-0.66
-115.68%
4.20
+144.65%
-9.41
+44.40%
-16.93
Net Income From Continuing Operations
-5.31
-1007.08%
-0.48
+94.31%
-8.44
+54.82%
-18.68
Depreciation Amortization Depletion
2.19
+0.55%
2.18
+50.97%
1.44
+150.69%
0.58
Depreciation
—
—
—
2.59
Depreciation And Amortization
2.19
+0.55%
2.18
+50.97%
1.44
+150.69%
0.58
Other Non Cash Items
2.47
+3.56%
2.39
-23.45%
3.12
+30.86%
2.38
Stock Based Compensation
1.82
+40.56%
1.29
+38.63%
0.93
+195.87%
0.32
Provisionand Write Offof Assets
-0.18
-142.12%
0.42
-61.29%
1.10
+80.00%
0.61
Asset Impairment Charge
0.18
0.00
—
—
Operating Gains Losses
-0.21
-183.78%
-0.07
+76.88%
-0.32
-4471.43%
-0.01
Gain Loss On Investment Securities
-0.27
-260.81%
-0.07
+76.95%
-0.32
-7925.00%
-0.00
Net Foreign Currency Exchange Gain Loss
—
—
—
-0.00
Change In Working Capital
-1.61
-5.63%
-1.53
+78.92%
-7.24
-240.73%
-2.13
Change In Receivables
-0.10
-103.75%
2.61
+156.23%
-4.64
-1241.62%
-0.35
Changes In Account Receivables
-0.10
-103.75%
2.61
+156.23%
-4.64
-1241.62%
-0.35
Change In Inventory
2.78
+937.05%
-0.33
-128.23%
1.18
+155.97%
-2.10
Change In Prepaid Assets
0.39
+4.81%
0.37
-73.48%
1.41
-48.16%
2.72
Change In Payables And Accrued Expense
-2.55
+4.92%
-2.68
-3181.61%
0.09
-72.29%
0.31
Change In Accrued Expense
-1.68
-62.38%
-1.03
-175.00%
-0.38
—
Change In Payable
-0.87
+47.18%
-1.65
-455.72%
0.46
+47.45%
0.31
Change In Account Payable
-0.87
+47.18%
-1.65
-455.72%
0.46
+47.45%
0.31
Change In Other Working Capital
-0.47
-932.61%
-0.05
+98.79%
-3.81
+0.42%
-3.83
Change In Other Current Assets
—
—
—
2.72
Change In Other Current Liabilities
-1.66
-14.46%
-1.45
+0.89%
-1.47
-231.63%
1.11
Investing Cash Flow
-8.54
-75.59%
-4.87
-59.80%
-3.04
-27.09%
-2.40
Cash Flow From Continuing Investing Activities
-8.54
-75.59%
-4.87
-59.80%
-3.04
-27.09%
-2.40
Net PPE Purchase And Sale
-0.54
+46.39%
-1.01
-255.99%
-0.28
-1.07%
-0.28
Purchase Of PPE
-0.54
+46.39%
-1.01
-255.99%
-0.28
-1.07%
-0.28
Capital Expenditure
-0.54
+46.39%
-1.01
-255.99%
-0.28
-1.07%
-0.28
Net Investment Purchase And Sale
-8.00
-107.57%
-3.85
-140.16%
9.60
+553.90%
-2.12
Purchase Of Investment
-24.20
-313.14%
-5.86
-2.75%
-5.70
+73.23%
-21.30
Sale Of Investment
16.20
+708.79%
2.00
-86.91%
15.30
-20.23%
19.18
Net Business Purchase And Sale
—
0.00
+100.00%
-12.36
0.00
Purchase Of Business
—
0.00
+100.00%
-12.36
0.00
Financing Cash Flow
4.25
-42.13%
7.35
-35.21%
11.34
-29.77%
16.15
Cash Flow From Continuing Financing Activities
4.25
-42.13%
7.35
-35.21%
11.34
-29.77%
16.15
Net Issuance Payments Of Debt
-1.19
+0.91%
-1.20
+65.74%
-3.51
+74.30%
-13.68
Issuance Of Debt
—
—
—
—
Repayment Of Debt
-1.19
+0.91%
-1.20
+65.74%
-3.51
+74.30%
-13.68
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
-0.53
+5.20%
-0.56
+77.87%
-2.52
+79.38%
-12.23
Net Long Term Debt Issuance
-0.53
+5.20%
-0.56
+77.87%
-2.52
+79.38%
-12.23
Short Term Debt Payments
-0.66
-2.79%
-0.65
+34.88%
-0.99
+31.25%
-1.44
Net Short Term Debt Issuance
-0.66
-2.79%
-0.65
+34.88%
-0.99
+31.25%
-1.44
Net Common Stock Issuance
7.82
-23.23%
10.18
-31.49%
14.86
-1.03%
15.02
Common Stock Payments
—
—
—
0.00
Repurchase Of Capital Stock
—
—
—
0.00
Net Other Financing Charges
-2.37
-45.55%
-1.63
-32480.00%
-0.01
+97.38%
-0.19
Changes In Cash
-4.95
-174.07%
6.68
+699.46%
-1.11
+64.88%
-3.17
Effect Of Exchange Rate Changes
0.00
+100.00%
-0.01
-25.00%
-0.00
-33.33%
-0.00
Beginning Cash Position
15.66
+74.35%
8.98
-11.08%
10.10
-23.93%
13.28
End Cash Position
10.71
-31.61%
15.66
+74.35%
8.98
-11.08%
10.10
Free Cash Flow
-1.20
-137.64%
3.19
+132.91%
-9.70
+43.66%
-17.21
Interest Paid Supplemental Data
0.77
-8.85%
0.85
-29.94%
1.21
-17.76%
1.47
Common Stock Issuance
7.82
-23.23%
10.18
-31.49%
14.86
-1.03%
15.02
Issuance Of Capital Stock
7.82
-23.23%
10.18
-31.49%
14.86
-50.49%
30.02
Net Preferred Stock Issuance
—
—
0.00
-100.00%
15.00
Preferred Stock Issuance
—
—
0.00
-100.00%
15.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category